Related Experiment Videos
A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable
Insights
Coronary bypass surgery (CBS) improves survival for specific coronary artery disease (CAD) patients. However, medical therapy is comparable or better for others, necessitating critical review of clinical trial data.
Area of Science:
- Cardiology
- Clinical Trials
- Evidence-Based Medicine
Background:
- Myocardial ischemia is a key factor in coronary artery disease (CAD) survival.
- Ischemia can be asymptomatic (silent).
- Coronary bypass surgery (CBS) offers benefits over medical treatment for certain ischemic events.
Purpose of the Study:
- To evaluate the comparative effectiveness of CBS versus medical therapy in patients with CAD.
- To identify specific patient subgroups who benefit most from CBS.
- To critically assess the methodologies and findings of randomized trials comparing CBS and medical therapy.
Main Methods:
- Review and analysis of randomized clinical trials comparing CBS and medical therapy for CAD.
- Examination of patient subgroups based on disease severity, left ventricular function, and exercise test results.
- Consideration of potential biases and limitations within trial data.
Main Results:
- CBS demonstrates improved survival in patients with left main CAD, extensive multi-vessel CAD, or specific proximal lesions.
- For other patient groups, medical therapy shows comparable or superior outcomes to CBS.
- Significant concerns exist regarding trial biostatistics, patient numbers, physician bias, and data interpretation.
Conclusions:
- CBS is superior for select CAD patients, particularly those with severe or complex disease.
- Medical therapy is a viable and often preferable alternative for many CAD patients.
- There is a critical need for transparent, detailed, and rigorously interpreted data from CAD clinical trials.
Abstract:
Myocardial ischemia is an important determinant of survival in patients with coronary artery disease (CAD) and it may be silent. Coronary bypass surgery (CBS) is more effective than medical treatment in the relief of myocardial ischemia, anginal pain, and of events that are related to myocardial ischemia such as episodes of angina and left ventricular dysfunction caused by ischemia. Patients with chronic, stable angina assigned to CBS have an improved survival if they have left main CAD, three-vessel CAD with normal or impaired left ventricular function, proximal left anterior descending CAD that is part of two-vessel CAD, or two- or 3-vessel CAD with a positive exercise test for ischemia. In other respects, patients assigned to medical therapy fare as well as or better than those assigned to surgical therapy. Many issues that cause concern with regard to the randomized trials were considered in detail. The greatest problems are biostatistical tenets, small numbers of patients randomized in many of the subgroups, physician bias before and after randomization, crossovers, and inappropriate conclusions and unjustified extrapolations of the results. Timely, detailed, and comprehensive publication of the methods and results of these clinical trials is necessary. Meticulous, detailed, and critical reading of all of the published data is urged.